GO:0016556 mRNA modification: Genes, Functions & Methods

GO:0016556 mRNA modification, also known as mRNA editing, refers to the covalent alteration of one or more nucleotides within an mRNA molecule to produce an mRNA molecule with a sequence that differs from that coded genetically. This biological process encompasses a diverse set of chemical changes, including methylation, acetylation, and isomerization, that expand the informational capacity of the transcriptome beyond the four canonical ribonucleotides. The most extensively studied mRNA modification is N6-methyladenosine (m6A), but other modifications such as 5-methylcytosine (m5C), N1-methyladenosine (m1A), N4-acetylcytidine (ac4C), and pseudouridine (Ψ) are increasingly recognized as key post-transcriptional regulators. These modifications are dynamically installed, recognized, and removed by specialized protein machineries, collectively termed writers, readers, and erasers, which together orchestrate the epitranscriptome. Understanding mRNA modification is critical because it directly impacts mRNA stability, splicing, nuclear export, translation efficiency, and decay, thereby shaping gene expression programs in development, immunity, and disease. For researchers, GO:0016556 provides a framework to investigate how chemical marks on mRNA influence cellular phenotypes and how their dysregulation contributes to pathologies such as cancer and metabolic disorders. Moreover, the therapeutic potential of mRNA modification is being harnessed in mRNA vaccine design and cancer immunotherapy, where controlled modification of synthetic mRNA improves stability and reduces immunogenicity. This article synthesizes authoritative QuickGO annotations and verified PubMed literature to provide a research-grade overview of mRNA modification, covering its molecular mechanisms, key genes, disease relevance, and experimental strategies for functional interrogation.

According to the Gene Ontology, GO:0016556 mRNA modification is defined as the covalent alteration of one or more nucleotides within an mRNA molecule to produce an mRNA molecule with a sequence that differs from that coded genetically. This process includes enzymatic reactions that add, remove, or isomerize chemical groups on mRNA nucleotides, such as methylation, acetylation, and pseudouridylation, and it is synonymous with mRNA editing. The definition emphasizes that the resulting mRNA sequence is chemically distinct from the genomically encoded sequence, thereby expanding the proteome and regulatory landscape beyond canonical transcription and translation.

mRNA modification is a central mechanism of post-transcriptional gene regulation that enables cells to rapidly and dynamically adjust protein output without altering DNA sequence. By controlling the fate of individual transcripts, mRNA modifications influence fundamental processes such as cell differentiation, stress responses, and immune surveillance. Dysregulation of this process is increasingly linked to human diseases, including cancer, where aberrant m6A levels drive tumor initiation and progression. Furthermore, the deliberate modification of mRNA is a cornerstone of therapeutic mRNA design, as it enhances stability and translational efficiency while mitigating innate immune activation. Thus, GO:0016556 represents both a fundamental biological process and a tractable target for therapeutic intervention.

The following genes encode the core writers, readers, and erasers that execute and regulate mRNA modification, as well as related factors with established roles in this process.

mRNA modification is regulated at multiple levels. The expression and activity of writer, reader, and eraser proteins are controlled by transcription, post-translational modifications, and interaction with regulatory factors. For example, METTL3 activity can be modulated by phosphorylation and SUMOylation, while FTO and ALKBH5 levels respond to metabolic and hypoxic signals. Additionally, the availability of cofactors such as S-adenosylmethionine (SAM) influences methyltransferase activity, linking mRNA modification to cellular metabolism. Signaling pathways, including mTOR and stress-responsive kinases, can alter the translation and stability of reader proteins, thereby indirectly shaping the epitranscriptome. This multilayered regulation ensures that mRNA modification is dynamically tuned to cellular state and environmental cues.

Dysregulation of mRNA modification is a hallmark of many cancers. Aberrant expression of m6A writers, erasers, and readers contributes to tumor initiation, progression, and metastasis by altering the stability and translation of oncogenes and tumor suppressors. For instance, elevated METTL3 can promote translation of oncogenic transcripts, while loss of FTO or ALKBH5 can lead to accumulation of m6A and altered gene expression programs. In liver cancer, mRNA modification-mediated translation regulation has been linked to metabolic reprogramming and therapy resistance. These findings underscore the potential of targeting mRNA modification enzymes for cancer therapy.

mRNA modification orchestrates stem cell self-renewal and differentiation decisions. m6A marks are dynamically remodeled during differentiation, and their deposition or removal influences the stability of transcripts encoding pluripotency factors and lineage specifiers. Disruption of writer or eraser function can impair stem cell maintenance and skew differentiation trajectories, highlighting the importance of mRNA modification in developmental biology and regenerative medicine.

mRNA modifications play critical roles in immune cell function and in the design of mRNA-based therapeutics. In cancer immunotherapy, modification of synthetic mRNA with m6A or pseudouridine can enhance translational efficiency and reduce innate immune activation, thereby improving vaccine efficacy. Conversely, dysregulated m6A in immune cells can contribute to autoimmunity and chronic inflammation. Understanding how mRNA modification shapes immune responses is therefore essential for optimizing immunotherapies.

Several methods are used to detect and quantify mRNA modifications. Antibody-based approaches such as m6A immunoprecipitation followed by sequencing (MeRIP-seq) enable transcriptome-wide mapping of m6A. Site-specific detection can be achieved using SELECT (single-base elongation- and ligation-based qPCR amplification method) or miCLIP. For non-m6A modifications, methods like m5C-RIP, m1A-seq, and ac4C-seq are employed. These techniques are essential for linking modifications to specific transcripts and for validating changes in writer, eraser, or reader mutants.

To assess the functional consequences of mRNA modification, researchers use reporter assays in which modified or unmodified transcripts are introduced into cells and their stability, translation, or localization is measured. Polysome profiling and ribosome profiling (Ribo-seq) can determine translation efficiency of modified mRNAs. RNA stability can be assessed by actinomycin D treatment followed by qPCR or RNA-seq. These assays help establish causal relationships between specific modifications and mRNA fate.

Proteomics and interactomics are used to identify proteins that bind to modified mRNAs and to characterize writer, reader, and eraser complexes. RNA pull-down followed by mass spectrometry can reveal readers of specific modifications. Proximity labeling techniques such as BioID or APEX can map the interactome of modification enzymes in living cells. These approaches provide insights into the composition and dynamics of the epitranscriptomic machinery.

CRISPR-Cas9 knockout, point-mutation knock-in, and overexpression screens enable systematic interrogation of mRNA modification genes. Pooled CRISPR screens can identify writers, readers, and erasers that modulate drug resistance or immune evasion. Knock-in of tagged alleles allows endogenous localization and interaction studies. These functional genomics approaches are powerful for dissecting the roles of individual modification components in disease models.

Researchers studying mRNA modification-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as cancer cell proliferation, stem cell differentiation, or immune evasion. Establishing causality requires precise genetic manipulation, and CRISPR-based models provide the gold standard for such investigations. EDITGENE offers a comprehensive suite of services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling rigorous functional interrogation of mRNA modification genes.

GO:0016556 mRNA modification is a fundamental biological process that expands the regulatory capacity of the transcriptome through covalent chemical alterations of mRNA nucleotides. The dynamic interplay of writers, readers, and erasers controls mRNA fate and influences diverse physiological and pathological states, including cancer, stem cell differentiation, and immune responses. As the therapeutic potential of mRNA modification continues to be realized in vaccine and immunotherapy development, functional interrogation of modification genes using CRISPR-based models will be essential. EDITGENE's comprehensive services empower researchers to dissect these mechanisms with precision and accelerate translation to clinical applications.